News Releases

Thanks to Weizmann research, a new and improved version of a detoxifying enzyme produced naturally by our livers may be able to protect us against otherwise deadly chemical attacks, such as Tokyo’s subway sarin incident that left 13 people dead and thousands more injured.

April 19, 2012

The “Man in the Moon” is actually craters filled with dark volcanic material. Why is this side of the moon the one that is always “looking” at Earth? Weizmann’s Prof. Oded Aharonson and colleagues found the answer.

March 12, 2012

Three updates from the Weizmann Institute: Weizmann is a European Integrated Structural Biology Infrastructure Core Centre; how cells are able to endure starvation; and an “on/off” switch in the brain helps regulate a biochemical signal related to stress.

February 24, 2012

Using a method he developed for determining the “family trees” of cells, Prof. Ehud Shapiro and a cross-disciplinary team of Weizmann scientists, including Prof. Nava Dekel, was able to prove—and disprove—some ideas about the female mammal’s egg supply.

February 23, 2012

The Weizmann Institute’s commercial arm has entered into a licensing agreement with Adobe for a bidirectional similarity method, developed by Prof. Michal Irani, to summarize visual data.

January 17, 2012

The Weizmann Institute and the Max Planck Society have launched a center to study humankind’s history in new ways, such as by using sophisticated technologies borrowed from physics.

January 11, 2012

Prof. Irit Sagi has successfully tricked the immune system into targeting an enzyme involved in the autoimmune process. Her synthetic molecules could lead to new treatments for Crohn’s and other autoimmune diseases.

December 26, 2011

The American Committee appoints Eleanore Levy as its first Director of Personalized Philanthropy. Levy will help donors maximize their philanthropic impact, while advancing the Institute’s goals.

December 19, 2011

The LHC at CERN in Geneva announced that it has seen “tantalizing hints” of the possible existence of the Higgs boson. Weizmann physicists have been key members of this search since 1987.

December 13, 2011

Patients with Type 1 diabetes who were treated with DiaPep277® in clinical trials saw benefits. Weizmann’s Prof. Irun Cohen developed the novel drug.

November 22, 2011